Hydroxychloroquine was no better than a placebo at preventing symptoms of COVID-19 among people exposed to the virus, according to research from the University of Minnesota Medical School.

The findings, published Wednesday in the New England Journal of Medicine, are the first from a major clinical trial looking at whether the medication might be useful as a prophylactic.

The study included 821 people who had been in close contact with a confirmed COVID-19 patient, putting them at an elevated risk of developing the illness themselves.

Read the full story here. 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.